Lukas Hainz

The transition from traditional stem cell therapies to more refined exosome-based treatments represents one of the most significant shifts in regenerative medicine during the middle of this decade. While stem cells offer immense healing potential, they carry inherent risks such as unwanted

Understanding the complex interplay between viral infections and lung function has long been a cornerstone of pediatric research aimed at reducing infant mortality during peak winter respiratory seasons. Bronchiolitis stands as the primary reason for hospital admissions among infants under one year

Managing the psychological weight of a terminal diagnosis remains one of the most formidable challenges in modern oncology, often manifesting as a profound fear of disease progression that affects between twenty and seventy percent of patients. A collaborative effort between the University of

The complexity of biological systems often leaves pharmaceutical researchers grappling with a vast "dark matter" of untreatable conditions, where nearly 90% of human biology remains untouched by current therapeutic interventions. This systemic limitation has historically led to a high-risk and

The global marketplace for pharmaceuticals has reached a critical inflection point where the sheer volume of counterfeit medications now threatens the fundamental integrity of international healthcare systems and patient safety alike. As criminal networks become more sophisticated in replicating

The global healthcare landscape is currently confronting a transformative challenge that necessitates a fundamental shift in how we approach chronic and life-threatening illnesses. With projections from the American Cancer Society suggesting that global cancer cases could reach 35 million annually

Lukas Hainz sits down with Ivan Kairatov, a distinguished biopharma expert with a deep background in research and development and a keen eye for technological innovation within the pharmaceutical industry. Together, they explore a recent breakthrough from the University of Cambridge that reimagines

The relentless pursuit of highly effective oncological interventions has historically been hampered by the inability of traditional pharmaceutical agents to distinguish accurately between malignant cells and healthy physiological structures. While chemotherapy and systemic radiation have saved

The relentless physical and psychological burden of chronic cholestatic pruritus often defines the daily existence of patients long before a clinical diagnosis is even finalized. For those living with rare liver diseases, the sensation of an internal, unreachable itch is not merely a symptom but a

The landscape of gastrointestinal oncology has shifted significantly as European regulators authorize a potent new weapon for combating aggressive tumors before they have the chance to spread. The European Commission has officially approved the use of AstraZeneca’s durvalumab, commercially known as